Domov › Rak požiralnika › New York

Klinične študije za Rak požiralnika v New York

28 študij za Rak požiralnika išče udeležence na lokacijah v New York.

Mesta v New York

Uradno besedilo študije (angleško)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
in še 2

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Hematology-Oncology Associates of Central NY, P.C. ( Site 4925), East Syracuse

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05319730

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Montefiore Medical Center-Einstein Campus, The Bronx
James J Peters VA Medical Center, The Bronx

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
in še 1

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06123338

Pan-tumor MRD Study

Guthrie Lourdes Memorial Hospital (GLMH), Binghamton
New York Cancer & Blood Specialists, Shirley

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06605404

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Icahn School of Medicine at Mount Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07217704

A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma

Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
in še 1

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07818018

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, New York
Research Site, New York
Research Site, New York
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07431281

Retrospective Review of Esophageal Cancer at MSKCC

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT05706558

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Hematology-Oncology Associates of Central NY, P.C. ( Site 8925), East Syracuse

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Hematology-Oncology Associates of Central NY, P.C. ( Site 6925), East Syracuse

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06469944

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07227168

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Columbia University Medical Center, New York

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT00288119

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cayuga Medical Center, Ithaca
Mt. Sinai, New York
Memorial Sloan Kettering Cancer Center, New York
in še 1

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT03526835

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Memorial Sloan Kettering Cancer Center, New York

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Brooklyn
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New Hyde Park
in še 7

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT04389632